{'fraction_non_alphanumeric': 0.04541154210028382, 'fraction_numerical': 0.02459791863765374, 'mean_word_length': 4.977401129943503, 'pattern_counts': {'":': 0, '<': 4, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Control of Maturity-Onset Diabetes by Monitoring Fasting Blood Glucose and Body Weight

The feasibility of reducing the fasting blood glucose (FBG) level to <6 mmol/L has been studied in all 84 maturity-onset diabetic (MOD) patients in three general practices. Only 35 (48%) were initially “well controlled” by this criterion, although 72 (86%) had no postprandial glycosuria. Seventy-one patients were monitored for 6 mo. With additional oral hypoglycemic therapy where necessary, the number of “well controlled” increased from 29 (41%) to 54 (76%), associated with a significant decrease in the hemoglobin A1. The patients were subsequently assessed at two 3-monthly intervals, and a fasting plasma glucose >4 and <6 mmol/L was usually maintained. All but two patients with a fasting glucose level < 6 mmol/L had fasting triglyceride concentrations < 2 mmol/L. The fasting blood glucose can be assayed in general practice with glucose-oxidase strips, and control by this means is simpler, cheaper, and more effective than regular urine glucose monitoring.